ExploreWatchlistsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Retained earnings

RaQualia Pharma Inc. (4579)

Market cap
¥22.3B
P/E ratio
-331.8x
Rakuoria Drug Discovery develops new pharmaceutical compounds through early-stage research and clinical trials, then licenses them to major pharmaceutical companies for revenue.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Dec 31, 2025227-597.98%
Dec 31, 2024-46-110.16%
Dec 31, 2023449-41.87%
Dec 31, 2022773+1457.54%
Dec 31, 202150-107.03%
Dec 31, 2020-706+612.05%
Dec 31, 2019-99-94.75%
Dec 31, 2018-1,890+140.59%
Dec 31, 2017-786+7.90%
Dec 31, 2016-728-93.01%
Dec 31, 2015-10,421+21.65%
Dec 31, 2014-8,567

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat